Current NDC auxiliary source row compounder:644

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 70092-335
Product Ndc: 70092-335
Product Ndc Digits: 70092335
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Ropivacaine PF 0.2% 250ml CADD-Y FSFF
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ropivacaine PF 0.2% 250ml CADD-Y FSFF
Dosage Form Name: INJECTION
Route Name: EPIDURAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: QuVa Pharma, Inc.
Establishment Name: QuVa Pharma, Inc.
Establishment Fei: [empty]
Substance Name: ROPIVACAINE HYDROCHLORIDE
Active Ingredients Info: 500 mg/250 mL
History Active Ingredients Raw: ROPIVACAINE HYDROCHLORIDE
History Active Ingredients Info Raw: 500 mg/250 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 70092-335-76
Package Ndc: 70092-335-76
Package Ndc Digits: 7009233576
Package Ndc11: 70092033576
Package Description: 250 mL in 1 CARTRIDGE (70092-335-76)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:644
Source Row Number: 644
Source Row Hash: 8b704e8adc7724520509d934655b58fc552f402fa7b6f5be994daf77ee1079a1
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "EPIDURAL",
    "PRODUCTNDC": "70092-335",
    "DEASCHEDULE": "",
    "LABELERNAME": "QuVa Pharma, Inc.",
    "SUBSTANCENAME": "ROPIVACAINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "70092-335-76",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Ropivacaine PF 0.2% 250ml CADD-Y FSFF",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Ropivacaine PF 0.2% 250ml CADD-Y FSFF",
    "PACKAGEDESCRIPTION": "250 mL in 1 CARTRIDGE (70092-335-76) ",
    "ACTIVEINGREDIENTSINFO": "500 mg/250 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:644
Source Row Number: 644
Status Scope: package
Lookup Ndc: 70092-335-76
Lookup Ndc Digits: 7009233576
Product Ndc: 70092-335
Product Ndc Digits: 70092335
Package Ndc: 70092-335-76
Package Ndc Digits: 7009233576
Package Ndc11: 70092033576
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 8b704e8adc7724520509d934655b58fc552f402fa7b6f5be994daf77ee1079a1
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20